Senna Plus (Major Pharmaceuticals)
Welcome to the PulseAid listing for the Senna Plus drug offered from Major Pharmaceuticals. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Major Pharmaceuticals |
NON-PROPRIETARY NAME: | standardized senna concentrate and docusate sodium |
SUBSTANCE NAME: | SENNOSIDES; DOCUSATE SODIUM |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2010-01-14 |
END MARKETING DATE: | 0000-00-00 |
Senna Plus HUMAN OTC DRUG Details:
Item Description | Senna Plus from Major Pharmaceuticals |
LABELER NAME: | Major Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 8.6; 50(mg/1; mg/1) |
START MARKETING DATE: | 2010-01-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0904-6339_9a880e33-65ac-4bd3-8189-c68b67526b38 |
PRODUCT NDC: | 0904-6339 |
APPLICATION NUMBER: | |
Other SENNOSIDES; DOCUSATE SODIUM Pharmaceutical Manufacturers / Labelers: